Mosaic ImmunoEngineering
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Mosaic ImmunoEngineering generated cash of -$679,236, which is more than the previous year. Cash used in financing activities reached the amount of $525,003 last year. Net change in cash is therefore -$126,596.

Cash Flow

Mosaic ImmunoEngineering Inc. (OTC:CPMV): Cash Flow
2012 -2.40M -1.22M -124.21K
2016 -1.57M 58.5K 0
2018 -880.28K 2.19M 0
2020 -760.76K -572.75K 0
2021 -679.23K 27.63K 525.00K

CPMV Cash Flow Statement (2012 – 2021)

2021 2019 2017 2015 2012
Cash at beginning of period
352.73K2.31M979.64K2.67M8.45M
Operating activities
Net income
-3.68M-798.46K-1.20M-1.26M-4.82M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
04897631.29K3.19K
Stock-based compensation expense
1.30M-26.07K243.89K00
Deferred income tax benefit 1.30M-26.07K243.89K00
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
27.49K028.25K00
Cash generated by operating activities
-679.23K-760.76K-880.28K-1.57M-2.40M
Investing activities
Purchases Of Investments
0-750K-2.7M-2.45M-5.19M
Investments In Property Plant And Equipment
00-1.46K0-1.99K
Acquisitions Net
27.63K177.24K00-650K
Cash generated by investing activities
27.63K-572.75K2.19M58.5K-1.22M
Financing activities
Common Stock Issued
00000
Payments for dividends
00000
Repurchases of common stock
0000-124.21K
Repayments of term debt
00000
Cash used in financing activities
525.00K000-124.21K
Net Change In Cash
-126.59K-1.33M1.31M-1.51M-3.75M
Cash at end of period
226.14K985.92K2.29M1.15M4.69M
Data sourceData sourceData sourceData sourceData source